SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

In this podcast, Dr. Briggs talk with Brendon Neuen about his paper in the December issue of JASN. His meta-analysis of the CREDENCE and EMPA-CKD clinical trials - shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.

Episode metadata supplied by the publisher feed · Published Dec 4, 2023

Embed this episode

Attribution link and audio player

Ready to play

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

0:00 21:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JASN Podcast?

This episode is 21 minutes long.

When was this JASN Podcast episode published?

This episode was published on December 4, 2023.

Can I download this JASN Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!